Maroof Zafar

Research Program Manager

University of Arkansas for Medical Sciences

staff

Biochemistry & Molecular Biology, College of Medicine

15 h-index 33 pubs 666 cited

Research Areas

Links

Research Group UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Maroof Zafar's research investigates molecular mechanisms underlying cancer development and treatment. His work includes studies on triple-negative breast cancer, focusing on multi-omics data integration to identify regulatory features. He has also examined the role of specific enzymes, such as tryptophan 2,3-dioxygenase, in DNA damage tolerance and repair in glioma cells, and the function of DNA polymerase kappa in glioblastoma replication. Zafar's publications also address the impact of genetic variations, like rare SNPs in the HELB gene, on cellular function and protein interactions. He has collaborated with researchers from the University of Arkansas for Medical Sciences and Lyon College on multiple shared publications.

Metrics

h-index: 15
Publications: 33
Citations: 666

Selected Publications

Rare SNP in the HELB gene interferes with RPA interaction and cellular function of HELB (2025) DOI
Rare SNP in the HELB gene interferes with RPA interaction and cellular function of HELB (2024) DOI
Anti-Programmed Death Ligand-1 Induced Acute Vision Loss in a Patient With Cancer-Associated Retinopathy (2022) DOI
A structural feature of Dda helicase which enhances displacement of streptavidin and trp repressor from <scp>DNA</scp> (2021) DOI
Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer (2021) DOI
DNA Polymerase Kappa Acts as a Barrier to Unrestrained Replication in Glioblastoma (2021) DOI
Inhibition of tryptophan 2,3-dioxygenase impairs DNA damage tolerance and repair in glioma cells (2021) DOI